Profiles

Keywords
Last Name
Institution

Meenakshi Jolly

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentInternal Medicine, Division of Rheumatology
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7004391081


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Azizoddin DR, Jolly M, Arora S, Yelin E, Katz P. Patient-Reported Outcomes Predict Mortality in Lupus. Arthritis Care Res (Hoboken). 2019 Aug; 71(8):1028-1035. PMID: 30144293.
      View in: PubMed
    2. Tóth DM, Ocskó T, Balog A, Markovics A, Mikecz K, Kovács L, Jolly M, Bukiej AA, Ruthberg AD, Vida A, Block JA, Glant TT, Rauch TA. Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine. Arthritis Rheumatol. 2019 Aug; 71(8):1265-1275. PMID: 30835944.
      View in: PubMed
    3. Lillis TA, Tirone V, Gandhi N, Weinberg S, Nika A, Sequeira W, Hobfoll SE, Block JA, Jolly M. Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus. Arthritis Care Res (Hoboken). 2019 Mar; 71(3):406-412. PMID: 29726637.
      View in: PubMed
    4. Hassan S, Smith MM, Block JA, Jolly M. Challenges to Practicing Rheumatology in an Academic Center. Rheum Dis Clin North Am. 2019 02; 45(1):27-37. PMID: 30447744.
      View in: PubMed
    5. Azizoddin DR, Gandhi N, Weinberg S, Sengupta M, Nicassio PM, Jolly M. Fatigue in systemic lupus: the role of disease activity and its correlates. Lupus. 2019 Feb; 28(2):163-173. PMID: 30580659.
      View in: PubMed
    6. Arora S, Nika A, Trupin L, Abraham H, Block J, Sequeira W, Yazdany J, Jolly M. Does Systemic Lupus Erythematosus Care Provided in a Lupus Clinic Result in Higher Quality of Care Than That Provided in a General Rheumatology Clinic? Arthritis Care Res (Hoboken). 2018 12; 70(12):1771-1777. PMID: 29609210.
      View in: PubMed
    7. Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. Clin Pharmacol Ther. 2019 08; 106(2):374-382. PMID: 30079582.
      View in: PubMed
    8. Gandhi N, Arora S, Sengupta M, Sequeira W, Jolly M, Block JA. Validation of SIMPLE Index for Lupus Disease Activity. J Clin Rheumatol. 2018 Sep; 24(6):313-318. PMID: 29517552.
      View in: PubMed
    9. Bhattacharya J, Pappas K, Toz B, Aranow C, Mackay M, Gregersen PK, Doumbo O, Traore AK, Lesser ML, McMahon M, Utset T, Silverman E, Levy D, McCune WJ, Jolly M, Wallace D, Weisman M, Romero-Diaz J, Diamond B. Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus. Mol Med. 2018 06 01; 24(1):24. PMID: 30134810.
      View in: PubMed
    10. Jolly M, Sequeira W, Block JA, Toloza S, Bertoli A, Blazevic I, Vila LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Mok CC, Weisman M, Clarke AE, Wallace D, Alarcón G. Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2018 Apr 25. PMID: 29693320.
      View in: PubMed
    11. Iwamoto T, Dorschner J, Jolly M, Huang X, Niewold TB. Associations between type I interferon and antiphospholipid antibody status differ between ancestral backgrounds. Lupus Sci Med. 2018; 5(1):e000246. PMID: 29387437.
      View in: PubMed
    12. Annapureddy N, Giangreco D, Devilliers H, Block JA, Jolly M. Psychometric properties of MDHAQ/RAPID3 in patients with systemic lupus erythematosus. Lupus. 2018 Jan 01; 961203318758503. PMID: 29451066.
      View in: PubMed
    13. Costedoat-Chalumeau N, Houssiau F, Izmirly P, Le Guern V, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Van Vollenhoven R, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. Clin Pharmacol Ther. 2018 Jun; 103(6):1074-1082. PMID: 28925027.
      View in: PubMed
    14. Azizoddin DR, Weinberg S, Gandhi N, Arora S, Block JA, Sequeira W, Jolly M. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus. Lupus. 2018 Apr; 27(5):728-737. PMID: 29087259.
      View in: PubMed
    15. Jolly M, Toloza S, Goker B, Clarke AE, Navarra SV, Wallace D, Weisman M, Mok CC. Disease-specific quality of life in patients with lupus nephritis. Lupus. 2018 Feb; 27(2):257-264. PMID: 28728507.
      View in: PubMed
    16. Kugasia A, Sehgal N, Dollear M, Sequeira W, Block JA, Jolly M. Practice patterns in longitudinal lupus care provision: patient and physician perspectives. Lupus. 2017 Dec; 26(14):1556-1561. PMID: 28659044.
      View in: PubMed
    17. Jolly M, Katz P. Systemic lupus erythematosus: The promise of PROMIS - is it ready for prime time in SLE? Nat Rev Rheumatol. 2017 08; 13(8):453-454. PMID: 28660907.
      View in: PubMed
    18. Brandt JE, Drenkard C, Kan H, Bao G, Dunlop-Thomas C, Pobiner B, Chang DJ, Jolly M, Lim SS. External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017 06; 69(6):842-848. PMID: 27564570.
      View in: PubMed
    19. Faridi MH, Khan SQ, Zhao W, Lee HW, Altintas MM, Zhang K, Kumar V, Armstrong AR, Carmona-Rivera C, Dorschner JM, Schnaith AM, Li X, Ghodke-Puranik Y, Moore E, Purmalek M, Irizarry-Caro J, Zhang T, Day R, Stoub D, Hoffmann V, Khaliqdina SJ, Bhargava P, Santander AM, Torroella-Kouri M, Issac B, Cimbaluk DJ, Zloza A, Prabhakar R, Deep S, Jolly M, Koh KH, Reichner JS, Bradshaw EM, Chen J, Moita LF, Yuen PS, Li Tsai W, Singh B, Reiser J, Nath SK, Niewold TB, Vazquez-Padron RI, Kaplan MJ, Gupta V. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017 Apr 03; 127(4):1271-1283. PMID: 28263189.
      View in: PubMed
    20. Azizoddin DR, Olmstead R, Cost C, Jolly M, Ayeroff J, Racaza G, Sumner LA, Ormseth S, Weisman M, Nicassio PM. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus. Lupus. 2017 Aug; 26(9):967-974. PMID: 28059025.
      View in: PubMed
    21. Inoue M, Shiozawa K, Yoshihara R, Yamane T, Shima Y, Hirano T, Jolly M, Makimoto K. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus. Lupus. 2017 Jul; 26(8):849-856. PMID: 27927882.
      View in: PubMed
    22. Devilliers H, Bonithon-Kopp C, Jolly M. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index. Lupus. 2017 Apr; 26(4):396-402. PMID: 27587460.
      View in: PubMed
    23. Annapureddy N, Devilliers H, Jolly M. Patient-reported outcomes in lupus clinical trials with biologics. Lupus. 2016 Sep; 25(10):1111-21. PMID: 27497256.
      View in: PubMed
    24. Antony A, Kandane-Rathnayake RK, Ko T, Boulos D, Hoi AY, Jolly M, Morand EF. Validation of the Lupus Impact Tracker in an Australian patient cohort. Lupus. 2017 Jan; 26(1):98-105. PMID: 27516435.
      View in: PubMed
    25. Jolly M, Kosinski M, Garris CP, Oglesby AK. Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2016 06; 68(6):1422-31. PMID: 26814452.
      View in: PubMed
    26. Jolly M, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin DL, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Hulot JS, Arora S, Amoura Z, Piette JC, Costedoat-Chalumeau N. Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels. Lupus. 2016 Jun; 25(7):735-40. PMID: 26876692.
      View in: PubMed
    27. Giangreco D, Devilliers H, Annapureddy N, Block JA, Jolly M. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus. Lupus. 2015 Dec; 24(14):1486-91. PMID: 26162686.
      View in: PubMed
    28. Jolly M, Thakkar A, Mikolaitis RA, Block JA. Caregiving, dyadic quality of life and dyadic relationships in lupus. Lupus. 2015 Aug; 24(9):918-26. PMID: 25661509.
      View in: PubMed
    29. Mok CC, Kosinski M, Ho LY, Chan KL, Jolly M. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 Feb; 67(2):297-304. PMID: 25156199.
      View in: PubMed
    30. Jolly M, Sequeira W, Block JA. Health and quality of life outcomes. Health Qual Life Outcomes. 2014 Dec 12; 12:173. PMID: 25495461.
      View in: PubMed
    31. Jolly M, Peters KF, Mikolaitis R, Evans-Raoul K, Block JA. Body image intervention to improve health outcomes in lupus: a pilot study. J Clin Rheumatol. 2014 Dec; 20(8):403-10. PMID: 25417675.
      View in: PubMed
    32. Khan SQ, Guo L, Cimbaluk DJ, Elshabrawy H, Faridi MH, Jolly M, George JF, Agarwal A, Gupta V. A Small Molecule ß2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy. Front Med (Lausanne). 2014; 1:45. PMID: 25593918.
      View in: PubMed
    33. Castrejón I, Tani C, Jolly M, Huang A, Mosca M. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol. 2014 Sep-Oct; 32(5 Suppl 85):S-85-95. PMID: 25365095.
      View in: PubMed
    34. Jolly M, Garris CP, Mikolaitis RA, Jhingran PM, Dennis G, Wallace DJ, Clarke A, Dooley MA, Parke A, Strand V, Alárcon GS, Kosinski M. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2014 Oct; 66(10):1542-50. PMID: 24757021.
      View in: PubMed
    35. Bourré-Tessier J, Clarke AE, Kosinski M, Mikolaitis-Preuss RA, Bernatsky S, Block JA, Jolly M. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus. Lupus. 2014 Dec; 23(14):1452-9. PMID: 25081500.
      View in: PubMed
    36. Jolly M, Francis S, Aggarwal R, Mikolaitis RA, Niewold TB, Chubinskaya S, Block JA, Scanzello C, Sequeira W. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus. Lupus. 2014 Aug; 23(9):881-8. PMID: 24786785.
      View in: PubMed
    37. Dua AB, Touma Z, Toloza S, Jolly M. Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep. 2013 Dec; 15(12):380. PMID: 24178589.
      View in: PubMed
    38. Gatla N, Annapureddy N, Sequeira W, Jolly M. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013 Sep; 19(6):334-40. PMID: 23965484.
      View in: PubMed
    39. Chrabot BS, Kariuki SN, Zervou MI, Feng X, Arrington J, Jolly M, Boumpas DT, Reder AT, Goulielmos GN, Niewold TB. Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Genes Immun. 2013 Dec; 14(8):471-8. PMID: 23965942.
      View in: PubMed
    40. Kaya A, Goker B, Cura ES, Tezcan ME, Tufan A, Mercan R, Bitik B, Haznedaroglu S, Ozturk MA, Mikolaitis-Preuss RA, Block JA, Jolly M. Turkish lupusPRO: cross-cultural validation study for lupus. Clin Rheumatol. 2014 Aug; 33(8):1079-84. PMID: 23934384.
      View in: PubMed
    41. Bourré-Tessier J, Clarke AE, Mikolaitis-Preuss RA, Kosinski M, Bernatsky S, Block JA, Jolly M. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol. 2013 Aug; 40(8):1327-33. PMID: 23772082.
      View in: PubMed
    42. Moldovan I, Cooray D, Carr F, Katsaros E, Torralba K, Shinada S, Ishimori M, Jolly M, Wilson A, Wallace D, Weisman M, Nicassio P. Pain and depression predict self-reported fatigue/energy in lupus. Lupus. 2013 Jun; 22(7):684-9. PMID: 23660302.
      View in: PubMed
    43. Jolly M, Toloza S, Block J, Mikolaitis R, Kosinski M, Wallace D, Durran-Barragan S, Bertoli A, Blazevic I, Vilá L, Cooray D, Moldovan I, Katsaros E, Weisman M, Torralba KM, Alarcón G. Spanish LupusPRO: cross-cultural validation study for lupus. Lupus. 2013 Apr; 22(5):431-6. PMID: 23554032.
      View in: PubMed
    44. Navarra SV, Tanangunan RM, Mikolaitis-Preuss RA, Kosinski M, Block JA, Jolly M. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines. Lupus. 2013 Mar; 22(3):262-7. PMID: 23340995.
      View in: PubMed
    45. Jolly M, Kazmi N, Mikolaitis RA, Sequeira W, Block JA. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures. J Am Acad Dermatol. 2013 Apr; 68(4):618-623. PMID: 23107310.
      View in: PubMed
    46. Dua AB, Aggarwal R, Mikolaitis RA, Sequeira W, Block JA, Jolly M. Rheumatologists' quality of care for lupus: comparison study between a university and county hospital. Arthritis Care Res (Hoboken). 2012 Aug; 64(8):1261-4. PMID: 22392683.
      View in: PubMed
    47. Koldobskaya Y, Ko K, Kumar AA, Agik S, Arrington J, Kariuki SN, Franek BS, Kumabe M, Utset TO, Jolly M, Skol AD, Niewold TB. Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus. Clin Dev Immunol. 2012; 2012:682018. PMID: 22988468.
      View in: PubMed
    48. Jolly M, Pickard AS, Mikolaitis RA, Cornejo J, Sequeira W, Cash TF, Block JA. Body image in patients with systemic lupus erythematosus. Int J Behav Med. 2012 Jun; 19(2):157-64. PMID: 21380770.
      View in: PubMed
    49. Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, Rodby RA, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori ML, Kosinsky M, Merrill JT, Weisman MH, Wallace DJ. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 Aug; 42(1):56-65. PMID: 22480408.
      View in: PubMed
    50. Jolly M, Pickard AS, Sequeira W, Wallace DJ, Solem CT, Mikolaitis RA, Fogg L, Weisman MH, Block JA, Cash TF. A brief assessment tool for body image in systemic lupus erythematosus. Body Image. 2012 Mar; 9(2):279-84. PMID: 22154813.
      View in: PubMed
    51. Agik S, Franek BS, Kumar AA, Kumabe M, Utset TO, Mikolaitis RA, Jolly M, Niewold TB. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes. J Rheumatol. 2012 Jan; 39(1):73-8. PMID: 22045845.
      View in: PubMed
    52. Trivedi T, Franek BS, Green SL, Kariuki SN, Kumabe M, Mikolaitis RA, Jolly M, Utset TO, Niewold TB. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:802581. PMID: 22131818.
      View in: PubMed
    53. Moldovan I, Katsaros E, Carr FN, Cooray D, Torralba K, Shinada S, Ishimori ML, Jolly M, Wallace DJ, Weisman MH, Nicassio PM. The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus. 2011 Oct; 20(12):1285-92. PMID: 21813589.
      View in: PubMed
    54. Toloza SM, Sequeira W, Jolly M. Treatment of lupus: impact on quality of life. Curr Rheumatol Rep. 2011 Aug; 13(4):324-37. PMID: 21633837.
      View in: PubMed
    55. Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M, Mikolaitis RA, Guerrero G, Utset TO, Drevlow BE, Zaacks LS, Grober JS, Cohen LM, Kirou KA, Crow MK, Jolly M, Niewold TB. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-a and serologic autoimmunity in lupus patients. J Immunol. 2011 Aug 01; 187(3):1298-303. PMID: 21705624.
      View in: PubMed
    56. Aggarwal R, Sequeira W, Kokebie R, Mikolaitis RA, Fogg L, Finnegan A, Plaas A, Block JA, Jolly M. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Arthritis Care Res (Hoboken). 2011 Jun; 63(6):891-8. PMID: 21312346.
      View in: PubMed
    57. Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, Green SL, Utset TO, Jolly M, James JA, Harley JB, Niewold TB. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011 Apr; 63(4):1044-53. PMID: 21162028.
      View in: PubMed
    58. Carr FN, Nicassio PM, Ishimori ML, Moldovan I, Katsaros E, Torralba K, Shinada S, Cooray D, Wallace DJ, Finck S, Jolly M, Wilson AL, Weisman MH. Depression predicts self-reported disease activity in systemic lupus erythematosus. Lupus. 2011 Jan; 20(1):80-4. PMID: 20937622.
      View in: PubMed
    59. Jolly M, Pickard SA, Mikolaitis RA, Rodby RA, Sequeira W, Block JA. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol. 2010 Sep; 37(9):1828-33. PMID: 20716659.
      View in: PubMed
    60. Jolly M. Pitfalls and opportunities in measuring patient outcomes in lupus. Curr Rheumatol Rep. 2010 Aug; 12(4):229-36. PMID: 20425520.
      View in: PubMed
    61. Toloza SM, Jolly M, Alarcón GS. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010 Aug; 12(4):237-49. PMID: 20461481.
      View in: PubMed
    62. Kariuki SN, Franek BS, Kumar AA, Arrington J, Mikolaitis RA, Utset TO, Jolly M, Crow MK, Skol AD, Niewold TB. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther. 2010; 12(4):R151. PMID: 20659327.
      View in: PubMed
    63. Kariuki SN, Franek BS, Mikolaitis RA, Utset TO, Jolly M, Skol AD, Niewold TB. Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients. J Biomed Biotechnol. 2010; 2010:826434. PMID: 20671926.
      View in: PubMed
    64. Lodolce JP, Kolodziej LE, Rhee L, Kariuki SN, Franek BS, McGreal NM, Logsdon MF, Bartulis SJ, Perera MA, Ellis NA, Adams EJ, Hanauer SB, Jolly M, Niewold TB, Boone DL. African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. J Immunol. 2010 Jun 15; 184(12):7001-9. PMID: 20483768.
      View in: PubMed
    65. Jolly M, Mikolaitis RA, Shakoor N, Fogg LF, Block JA. Education, zip code-based annualized household income, and health outcomes in patients with systemic lupus erythematosus. J Rheumatol. 2010 Jun; 37(6):1150-7. PMID: 20360192.
      View in: PubMed
    66. Salloum R, Franek BS, Kariuki SN, Rhee L, Mikolaitis RA, Jolly M, Utset TO, Niewold TB. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 2010 Feb; 62(2):553-61. PMID: 20112359.
      View in: PubMed
    67. Jolly M, Pickard AS, Wilke C, Mikolaitis RA, Teh LS, McElhone K, Fogg L, Block J. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis. 2010 Jan; 69(1):29-33. PMID: 19126561.
      View in: PubMed
    68. Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, Block JA, Jolly M. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009 Jun; 36(6):1209-16. PMID: 19369452.
      View in: PubMed
    69. Mody S, Jolly M, Kwasny MJ, Block JA. Patient reported outcomes and analgesia use in osteoarthritis of the knee. Osteoarthritis Cartilage. 2008 Nov; 16(11):1294-9. PMID: 18456521.
      View in: PubMed
    70. Jolly M, Hill A, Mataria M, Agarwal S. Influence of an interactive joint model injection workshop on physicians' musculoskeletal procedural skills. J Rheumatol. 2007 Jul; 34(7):1576-9. PMID: 17516616.
      View in: PubMed
    71. Govindappa V, Hicks S, Wichter M, Jolly M. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus. Arthritis Rheum. 2007 Mar 15; 57(2):352-4. PMID: 17330286.
      View in: PubMed
    72. Jolly M, Danila MI, Danilla M. Tattoo: inflicted vasculitis? J Clin Rheumatol. 2007 Feb; 13(1):49. PMID: 17278953.
      View in: PubMed
    73. Jolly M, Patel P. Looking beyond the ordinary: genital lupus. Arthritis Rheum. 2006 Oct 15; 55(5):821-2. PMID: 17013843.
      View in: PubMed
    74. Becker MA, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin North Am. 2006 May; 32(2):275-93, v-vi. PMID: 16716880.
      View in: PubMed
    75. Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005 Sep; 32(9):1706-8. PMID: 16142864.
      View in: PubMed
    76. Jolly M. Discoid lupus erythematosus after tattoo: Koebner phenomenon. Arthritis Rheum. 2005 Aug 15; 53(4):627. PMID: 16082645.
      View in: PubMed
    77. Jolly M, Curran JJ. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis. J Clin Rheumatol. 2005 Aug; 11(4):213-5. PMID: 16357759.
      View in: PubMed
    78. Jolly M. The risk of cardiac events among patients with systemic lupus erythematosus: comment on the article by Costenbader et al. Arthritis Rheum. 2005 Jun 15; 53(3):476. PMID: 15934113.
      View in: PubMed
    79. Jolly M. Association of rheumatologic disease with preeclampsia. Obstet Gynecol. 2004 Nov; 104(5 Pt 1):1105-6; author reply 1106. PMID: 15516414.
      View in: PubMed
    80. Jolly M. Hormone replacement therapy in rheumatoid arthritis. J Rheumatol. 2004 Jul; 31(7):1462-3; author reply 1463. PMID: 15229974.
      View in: PubMed
    81. Jolly M, Curran JJ. Chlamydial infection preceding the development of rheumatoid arthritis: a brief report. Clin Rheumatol. 2004 Oct; 23(5):453-5. PMID: 15459816.
      View in: PubMed
    82. Jolly M, Curran JJ, Ellman M. Benign angiopathy of the central nervous system. J Clin Rheumatol. 2004 Apr; 10(2):80-2. PMID: 17043471.
      View in: PubMed
    83. Jolly M, Utset TO. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus. 2004; 13(12):924-6. PMID: 15645747.
      View in: PubMed
    84. Jolly M, Laumann AE, Shea CR, Utset TO. Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus. Lupus. 2004; 13(1):64-9. PMID: 14870920.
      View in: PubMed
    85. Jolly M, Smaron M, Olsen Utset T, Ellman M. Are isolated antinucleolar antibodies a marker of scleroderma? J Clin Rheumatol. 2003 Oct; 9(5):291-5. PMID: 17041478.
      View in: PubMed
    86. Jolly M, Curran JJ. Underuse of intra-articular and periarticular corticosteroid injections by primary care physicians: discomfort with the technique. J Clin Rheumatol. 2003 Jun; 9(3):187-92. PMID: 17041456.
      View in: PubMed
    Jolly's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description